Low-Dose Oral Cannabis Reversed Insulin Resistance in Diabetic Rats Through Different Mechanisms at Different Fat Sites
A specific low dose of oral cannabis (1.25 mg/kg THC equivalent) reversed insulin resistance in obese diabetic rats, but the mechanism differed between peritoneal fat (activated fat "beigeing" genes) and intramuscular fat (increased mitochondrial activity).
Quick Facts
What This Study Found
Cannabis at 1.25 mg/kg body weight (relative to THC content) reversed insulin resistance, while higher doses did not. In peritoneal fat, Cidea and UCP1 gene expression (fat beigeing markers) significantly increased. In intramuscular fat, mitochondrial activity increased significantly instead, without beigeing markers.
Key Numbers
Effective dose: 1.25 mg/kg body weight (THC equivalent). Higher doses ineffective. Cidea and UCP1 significantly increased in peritoneal fat. Mitochondrial activity significantly increased in intramuscular fat.
How They Did This
Obese streptozotocin-induced diabetic rat model with oral cannabis administration at multiple doses, comparing effects at peritoneal and intramuscular fat depots.
Why This Research Matters
The dose-dependent reversal of insulin resistance, where only the lowest dose worked, challenges assumptions that more is better. The finding that different fat depots respond through different mechanisms adds complexity to understanding how cannabis affects metabolism.
The Bigger Picture
Epidemiological studies have repeatedly found that cannabis users have lower rates of obesity and diabetes despite increased caloric intake. This animal study offers a possible mechanism, though the narrow effective dose range raises questions about translating these findings to humans.
What This Study Doesn't Tell Us
Animal model using streptozotocin-induced diabetes, which differs from naturally occurring type 2 diabetes. Only tested oral cannabis, not isolated cannabinoids. Small sample typical of animal studies. Cannot directly extrapolate doses to humans.
Questions This Raises
- ?Why did only the lowest dose reverse insulin resistance?
- ?Could this dose-response pattern explain contradictory findings in human metabolic studies?
Trust & Context
- Key Stat:
- Only the lowest cannabis dose (1.25 mg/kg THC) reversed insulin resistance
- Evidence Grade:
- Animal study using a streptozotocin-induced diabetes model. Results are preliminary and require human validation.
- Study Age:
- Published in 2023.
- Original Title:
- Effect of oral cannabis administration on the fat depots of obese and streptozotocin-induced diabetic rats.
- Published In:
- Phytotherapy research : PTR, 37(5), 1806-1822 (2023)
- Authors:
- Ramlugon, Sonaal, Levendal, Ruby-Ann(2), Frost, Carminita L(2)
- Database ID:
- RTHC-04866
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Can cannabis treat diabetes?
In this rat study, a specific low dose of oral cannabis reversed insulin resistance, but higher doses did not. This is preclinical evidence and has not been confirmed in humans.
How did cannabis affect fat in this study?
It activated fat "beigeing" genes in belly fat and increased mitochondrial activity in muscle fat, suggesting different mechanisms at different fat sites.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-04866APA
Ramlugon, Sonaal; Levendal, Ruby-Ann; Frost, Carminita L. (2023). Effect of oral cannabis administration on the fat depots of obese and streptozotocin-induced diabetic rats.. Phytotherapy research : PTR, 37(5), 1806-1822. https://doi.org/10.1002/ptr.7694
MLA
Ramlugon, Sonaal, et al. "Effect of oral cannabis administration on the fat depots of obese and streptozotocin-induced diabetic rats.." Phytotherapy research : PTR, 2023. https://doi.org/10.1002/ptr.7694
RethinkTHC
RethinkTHC Research Database. "Effect of oral cannabis administration on the fat depots of ..." RTHC-04866. Retrieved from https://rethinkthc.com/research/ramlugon-2023-effect-of-oral-cannabis
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.